Thioether excretion, urinary mutagenicity, and metabolic phenotype in smokers. 1994

B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
Department of Pharmacology and Physiology, University of Zaragoza, Spain.

In 81 healthy individuals (51 smokers and 30 nonsmokers) biological indicators of internal exposure to electrophiles derived from tobacco smoke through metabolism were evaluated. Subgroups of smokers have been established in relation to the amount and type of tobacco smoked. Acetylator and hydroxylator phenotypes have been used as biomarkers of genetically determined susceptibility to cancer development. Urinary concentrations of thioethers (UT) and mutagenicity, with S9 mix for microsomal activation (MI-S9), were higher in smokers in relation to the level of tobacco consumption, but not to the type of tobacco. The "Slow acetylators-rapid oxidizers" category was not significant from the "rapid acetylators-rapid oxidizers" for values of UT and MI-S9. Data suggest that the biomarkers of exposure used in this study lack the necessary specificity to ascertain genetically determined susceptibility to cancer induced by tobacco smoking.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
July 1991, Journal of the National Cancer Institute,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
December 1990, Journal of the National Cancer Institute,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
October 1995, Mutation research,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
June 1979, International archives of occupational and environmental health,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
January 1988, International archives of occupational and environmental health,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
January 1990, Contributions to nephrology,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
August 1985, The Tokai journal of experimental and clinical medicine,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
November 2001, Journal of toxicology and environmental health. Part A,
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
August 1982, Lancet (London, England),
B Sinués, and P Rueda, and J Benítez, and M A Saenz, and M L Bernal, and J Lanuza, and O Alda, and A Tres, and M Bartolome
June 1991, Journal of toxicology and environmental health,
Copied contents to your clipboard!